price
EP
NASDAQ · EPRX
Eupraxia Pharmaceuticals Inc.
Healthcare · Biotechnology
$6.83
Down-$0.05 (-0.73%)
Updated Nov 2, 2026, 8:12 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 216.11M
- P/E ratio
- -7.17
- Dividend yield
- 0.00%
- 52-week range
- $5.25 – $9.32
- Volume
- 1.22M
- Avg. volume
- 144.03K
Price performance · EPRX
EPRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
EPRX closed at $6.83 after 20 trading sessions, down 11.81% for the selected period.
- Last close
- $6.83
- Period change
- -11.81%
- Period low
- $6.59
- Period high
- $7.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $7.10 | $7.10 | $6.41 | $6.83 | 1.22M |
| Oct 29, 2026 | $7.44 | $7.51 | $7.10 | $7.25 | 1.02M |
| Oct 28, 2026 | $7.08 | $7.42 | $6.90 | $7.38 | 419.99K |
| Oct 27, 2026 | $6.90 | $7.16 | $6.64 | $7.08 | 486.21K |
| Oct 26, 2026 | $6.81 | $7.00 | $6.695 | $6.85 | 540.29K |
| Oct 23, 2026 | $7.51 | $7.61 | $6.70 | $6.87 | 348.8K |
| Oct 22, 2026 | $7.70 | $7.94 | $7.545 | $7.59 | 391.89K |
| Oct 21, 2026 | $7.65 | $7.76 | $7.55 | $7.73 | 348.32K |
| Oct 20, 2026 | $6.87 | $7.76 | $6.87 | $7.59 | 938.69K |
| Oct 19, 2026 | $6.67 | $7.05 | $6.67 | $6.95 | 398.53K |
| Oct 16, 2026 | $6.78 | $6.88 | $6.56 | $6.62 | 582.91K |
| Oct 15, 2026 | $6.60 | $6.82 | $6.49 | $6.77 | 594.85K |
| Oct 14, 2026 | $6.59 | $6.805 | $6.42 | $6.59 | 278.23K |
| Oct 13, 2026 | $7.29 | $7.29 | $6.62 | $6.68 | 1.52M |
| Oct 12, 2026 | $7.46 | $7.56 | $7.2501 | $7.32 | 250.67K |
| Oct 9, 2026 | $7.57 | $7.70 | $7.275 | $7.46 | 1.05M |
| Oct 8, 2026 | $7.69 | $7.75 | $7.34 | $7.57 | 637.05K |
| Oct 7, 2026 | $7.64 | $7.88 | $7.475 | $7.78 | 853.31K |
| Oct 6, 2026 | $7.81 | $8.07 | $7.67 | $7.74 | 1.64M |
| Oct 5, 2026 | $7.20 | $7.93 | $7.07 | $7.745 | 1.77M |
Latest EPRX news
The latest Smart Investors Daily articles mentioning EPRX.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

